Cell line · CVCL_0622
Papers23
1 to 20 of 23
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Ceritinib induces ferroptosis via TRIM21-mediated GLUT1 ubiquitination and AMPK-driven metabolic reprogramming in breast cancer. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Antibodies blocking PlGF or VEGF interactions with the NRP1 receptor mediate antiproliferative effects. | J Biol Chem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progression. | Mol Cancer | 2025 | Its Methods give the RRID and name the line | PubMed | |
| TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer. | Cancer Discov | 2024 | Its Methods give the RRID and name the line | PubMed | |
| AEP-cleaved DDX3X induces alternative RNA splicing events to mediate cancer cell adaptation in harsh microenvironments. | J Clin Invest | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer. | Cancers (Basel) | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | Cellosaurus cites it | PubMed | |
| An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines. | Cancer Res | 2019 | Cellosaurus cites it | PubMed | |
| Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line. | Int J Cancer | 2018 | Cellosaurus cites it | PubMed | |
| TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24- cancer cells. | Elife | 2017 | Its Methods give the RRID and name the line | PubMed | |
| TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression. | Genome Med | 2015 | Cellosaurus cites it | PubMed | |
| miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs. | Breast Cancer Res | 2013 | Cellosaurus cites it | PubMed | |
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. | Nature | 2012 | Cellosaurus cites it | PubMed | |
Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues. | BMC Cancer | 2010 | Cellosaurus cites it | PubMed | |
| Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. | Breast Cancer Res Treat | 2010 | Cellosaurus cites it | PubMed | |
| Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. | Breast Cancer Res Treat | 2006 | Cellosaurus cites it | PubMed | |
| BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. | Cancer Res | 2006 | Cellosaurus cites it | PubMed | |
| Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer. | Carcinogenesis | 2005 | Cellosaurus cites it | PubMed | |
| Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. | Genes Chromosomes Cancer | 2003 | Cellosaurus cites it | PubMed | |
| Further evidence to support the melanocytic origin of MDA-MB-435. | Mol Pathol | 2002 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0622/papers